US FDA to hold off action on weight-loss drug copies pending court ruling
(Reuters) -The U.S. Food and Drug Administration said on Monday it will not take action against compounding pharmacies making copies of Novo Nordisk’s weight-loss drug Wegovy until a federal court delivers its ruling in a lawsuit against the agency. The health regulator announced last month that there was no longer a shortage of Novo’s Wegovy …
US FDA to hold off action on weight-loss drug copies pending court ruling Read More »










